6533b82efe1ef96bd12927f7

RESEARCH PRODUCT

Although rare, severe complications following intravesical bacillus Calmette-Guerin treatment should not be overlooked!

Vincenzo Serretta

subject

Microbiology (medical)Malemedicine.medical_specialtyAntineoplastic AgentsGastroenterologySettore MED/24 - UrologiaInternal medicineparasitic diseasesmedicineAdjuvant therapyIntravesical bacillus Calmette-GuerinAnimalsHumansBacillus (shape)Mycobacterium bovisBladder cancerGeneral Immunology and Microbiologybiologybusiness.industryGeneral Medicinebiology.organism_classificationmedicine.diseaseMycobacterium bovisbladder cancer BCG toxicityInfectious DiseasesSystemic toxicityUrinary Bladder NeoplasmsBCG VaccinebusinessBCG vaccine

description

An interesting series of 22 patients affected by severe systemic toxicity following bacillus Calmette-Guerin (BCG) intravesical adjuvant therapy for bladder cancer is presented in this issue of Inf...

yearjournalcountryeditionlanguage
2015-07-14Infectious diseases (London, England)
10.3109/23744235.2015.1055795https://pubmed.ncbi.nlm.nih.gov/26077036